MHRA approves Tisotumab vedotin for the treatment of cervical cancer

European Medicines Agency validates Type II Variation Application for PADCEV (Enfortumab vedotin) with KEYTRUDA (Pembrolizumab)...

Celltrion’s ADC anticancer drug ‘CT-P70’ receives Fast Track Designation from the US FDA

IDEAYA Biosciences announces IND clearance for IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 ADC targeting...

Kelun-Biotech and Crescent Biopharma announce strategic partnership to develop and commercialize novel oncology therapeutics

SK Biopharm secures European actinium‑225 supply from Germany’s Eckert & Ziegler